Echo of silence
Silent mutations, RNA splicing, and neuromuscular diseases
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Decoding of the human genome sequence opened a treasure trove for scientists around the world.1,2⇓ Out of 2.9 gigabases of the human genome, only 1.1 to 1.4% is ultimately translated into protein. In contrast with previous estimates of ∼120,000 genes,3 preliminary analysis of the entire genome sequence revealed ∼31,000 genes: only twice as many as a worm (∼18,000) or a fly (∼13,000). The question then arises: what makes us human? Compared to the number of genes, the full set of proteins (proteome) inside our bodies is complex in both structure and function. A single gene producing a single protein is no longer the answer. A gene is defined as a transcriptional unit that consists of short exons (sequences that are expressed as protein) interrupted by large chunks of intervening sequences, introns. When RNA is transcribed from a gene, introns are spliced out and exons are joined together with remarkable precision. A direct consequence of RNA splicing is a possibility of different combinations of exons spliced together (alternative splicing) producing multiple isoforms of messenger RNA (mRNA) encoding different proteins from the same gene.4 According to current estimates, ∼60% of human genes are alternatively spliced, higher than any other species.1 Indeed, alternative splicing is assumed to be responsible for much of the complexity of human proteome.
Accurate splicing requires signaling sequences within an intron and an exon that are recognized by components of large splicing machinery. Splice signaling sequences are common targets for mutations in genetic …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Ann Yeh and Dr. Daniela Castillo Villagrán
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Articles
SMN1 gene, but not SMN2, is a risk factor for sporadic ALSP. Corcia, W. Camu, J. -M. Halimi et al.Neurology, August 23, 2006 -
Articles
SMN genotypes producing less SMN protein increase susceptibility to and severity of sporadic ALSJ. H. Veldink, S. Kalmijn, A. H. Van der Hout et al.Neurology, August 10, 2005 -
Brief Communications
Splicing mosaic of the myophosphorylase gene due to a silent mutation in McArdle diseaseI. Fernandez-Cadenas, A.L. Andreu, J. Gamez et al.Neurology, November 24, 2003 -
Articles
Preimplantation genetic diagnosis for spinal muscular atrophy type IL. Fallon, G.L. Harton, M.E. Sisson et al.Neurology, September 01, 1999